RIDGE
DEAD

Serial Number

97876248

Owner

Tenaya Therapeutics, Inc.

Attorney

Aaron D. Hendelman

First Use Date

Feb 26, 2024

Filing Date

Apr 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RIDGE Trademark

Serial Number: 97876248

RIDGE is a trademark filed by Tenaya Therapeutics, Inc. on April 6, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Tenaya Therapeutics, Inc.

171 Oyster Point Blvd., Suite 500
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 6, 2023

Registration Date

Not Registered

First Use Anywhere

February 26, 2024

First Use in Commerce

February 26, 2024

Published for Opposition

March 26, 2024

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Providing information on clinical studies via an interactive website

Business consulting and business project management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and business management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, business management of clinical trial execution; providing technical business and marketing consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials of others, clinical trial subject recruitment and enrollment for clinical trials of others, and processing business documents relating to clinical trials, and information management services; data management services for use in managing clinical data, provided to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data for business purposes; statistical analysis for business purposes; preparing and placing advertisements for others, namely, to recruit subjects for participation in clinical trials; providing referrals of subjects for enrollment in clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 26, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 26, 2026 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 10, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 10, 2025 GNFR
SU - FINAL REFUSAL - WRITTEN
Oct 10, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2025 CRFA
ASSIGNED TO LIE
Sep 15, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 30, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 30, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 25, 2025 SUPC
TEAS STATEMENT OF USE RECEIVED
May 20, 2025 EISU
USE AMENDMENT FILED
May 19, 2025 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 28, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2025 AITU
SOU EXTENSION 1 FILED
Nov 15, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 15, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 21, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 2, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2023 NWOS
NEW APPLICATION ENTERED
Apr 10, 2023 NWAP